Foreign enterprises bank on trade fair for business growth in Chinese market Foreign medical aesthetics players have been flocking to the China International Import Expo in light of the ferocious appetite of Chinese consumers banking on their solutions for better outer appearance. Among the companies making their debut at this year"s event is Swiss dermatologic and skincare products provider Galderma, which on Nov 7 announced that its new hyaluronic acid filler product Restylane Defyne has received approval for sale in China from National Medical Products Administration. Known for its hyaluronic acid fillers and botulinum neuromodulator, Galderma had also announced that

Japanese cosmetics company Shiseido showcased an array of technology-backed skincare products during the fourth China International Import Expo to cater to Chinese consumers who are increasingly technology-conscious and digitally savvy. Shiseido exhibited its "Second Skin" technology for its first-ever appearance outside its home turf, a technology that is an "exciting, ground breaking and revolutionary" solution to eye puffiness, according to Shiseido China CEO Kentaro Fujiwara. "We use science and technology to deepen our understanding of Asian beauty. We then take these insights and use them to develop products and solutions specifically for Asian consumers," Fujiwara said. The company also debuted